Concepedia

Catarina Guimarães‐Teixeira

CG

8

Publications

276

Citations

8

H-Index

2020

Active since

Affiliations

Instituto Português de Oncologia Francisco Gentil(Current)

Universidade do Porto

IPO Porto

Princess Máxima Center

Breast Center

Catarina Guimarães‐Teixeira is an author at Instituto Português de Oncologia Francisco Gentil specializing in medicine, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

2020–2022

8

Publications

8

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer

Daniela Barros‐Silva, João Lobo, Catarina Guimarães‐Teixeira et al. · Cancers · 2020 · 85 citations · Full text

The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors

Vera Miranda‐Gonçalves, João Lobo, Catarina Guimarães‐Teixeira et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 54 citations · Full text

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors

João Lobo, Catarina Guimarães‐Teixeira, Daniela Barros‐Silva et al. · Cancers · 2020 · 31 citations · Full text

, , +16

Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes

Catarina Guimarães‐Teixeira, Daniela Barros‐Silva, João Lobo et al. · Journal of Personalized Medicine · 2021 · 26 citations · Full text

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors

João Lobo, Vera Constâncio, Catarina Guimarães‐Teixeira et al. · Molecular Oncology · 2021 · 22 citations · Full text

Rows per page

1–5 of 8